MedTrace Logo

Antibiotics After Breast Reduction:Clinical Trial With Randomization

NCT02569866 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2018-04-20

No results posted yet for this study

Summary

This study was designed to determine the role of antibiotics reduction mammaplasty influence surgical site infections rates.

Conditions

  • Surgical Site Infection

Interventions

DRUG

Cephalexin

Capsules containing cephalexin/500mg

DRUG

Placebo

Capsules containing placebo/500mg

Sponsors & Collaborators

  • Universidade do Vale do Sapucai

    collaborator OTHER

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Lydia M Ferreira, PhD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-05-31
Completion
2016-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569866 on ClinicalTrials.gov